ThinkEquity LLC

17 State Street, 41^st Fl
New York, NY 10004

March 27, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

100 F Street, N.E.

Mail Stop 3030

Washington, D.C. 20549

Re:	G Medical Innovations Holdings Ltd
	Registration Statement on Form F-1, as amended
	Filed February 1, 2023
	File No. 333-269496

Ladies and Gentlemen:

In connection with the Registration Statement on Form F-1 of G Medical Innovations Holdings Ltd., the undersigned, which is acting as the representative of the underwriters of the offering, hereby requests acceleration of the effective date and time of the Registration Statement to 5:00 p.m., Eastern Time, on March 29, 2023, or as soon thereafter as practicable, pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Act”).

Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.

Very truly yours,
ThinkEquity LLC
By:	/s/ Eric Lord
Name:	Eric Lord
Title:	Head of Investment Banking